Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AtriCure (ATRC) FCF Margin (2016 - 2025)

Historic FCF Margin for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to 17.96%.

  • AtriCure's FCF Margin rose 38100.0% to 17.96% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.37%, marking a year-over-year increase of 66300.0%. This contributed to the annual value of 0.16% for FY2024, which is 20400.0% up from last year.
  • Per AtriCure's latest filing, its FCF Margin stood at 17.96% for Q3 2025, which was up 38100.0% from 13.92% recorded in Q2 2025.
  • AtriCure's 5-year FCF Margin high stood at 17.96% for Q3 2025, and its period low was 37.56% during Q1 2022.
  • Over the past 5 years, AtriCure's median FCF Margin value was 2.46% (recorded in 2021), while the average stood at 3.91%.
  • Its FCF Margin has fluctuated over the past 5 years, first crashed by -196100bps in 2022, then skyrocketed by 305200bps in 2023.
  • AtriCure's FCF Margin (Quarter) stood at 3.29% in 2021, then crashed by -42bps to 4.69% in 2022, then soared by 125bps to 1.17% in 2023, then soared by 117bps to 2.53% in 2024, then soared by 610bps to 17.96% in 2025.
  • Its FCF Margin was 17.96% in Q3 2025, compared to 13.92% in Q2 2025 and 10.68% in Q1 2025.